Mesa Labs Q2 FY22 revenue $35.84M (+12%), net income up 39% to $3.72M

MESA LABORATORIES INC /CO/

2022-Q2 EPS reported $1.07 revenue$70,760,000

Revenue $35.84M (+12% YoY); operating income $4.20M (-6%); net income $3.72M (+39%); diluted EPS $0.70 vs $0.51.
Sterilization & Disinfection Control organic growth 21%; Biopharma Development organic growth 16%; Continuous Monitoring revenue record (+18%).
Instrument division revenue down 8% due to component supply and labor constraints; backlog increased.
Non-GAAP adjusted operating income $9.997M (flat YoY); adjusted diluted EPS $1.87 vs $1.91.
Completed acquisition of Agena Bioscience on Oct 20, 2021, adding Clinical Genomics capabilities.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.